18 results on '"Ma, Hong"'
Search Results
2. WED-388 Safety, tolerability, and hepatitis B surface antigen reduction of HT-101 in chronic hepatitis B patients: preliminary results from a phase I b study
3. WED-386 A double-blind, placebo-controlled, single-ascending dose phase I a study to evaluate the safety, tolerability, and pharmacokinetics of HT-101, an investigational small interfering ribonucleic acid targeting hepatitis B virus in Chinese healthy subjects
4. LBP-037 Role of early on-treatment serum hepatitis B virus RNA declines in the prediction of hepatocellular carcinoma risk in patients with chronic hepatitis B
5. Clinical Features and Long-Term Outcomes of Patients Diagnosed with MASLD, MAFLD, or Both
6. Novel, high accuracy prediction models of hepatocellular carcinoma based on longitudinal data and cell-free DNA signatures
7. OS-033 - Novel, high accuracy prediction models of hepatocellular carcinoma based on longitudinal data and cell-free DNA signatures
8. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
9. A phase 2, open-label study of pan-genotype regimen of SH229 plus daclatasvir in Chinese patients with chronic hepatitis C virus infection
10. Efficacy and safety of rivaroxaban in portal vein thrombosis in patients with liver decompensated cirrhosis
11. A combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels
12. Diagnostic value of magnetic resonance elastography in cirrhotic portal hypertension
13. SAT-336-lLver stiffness measurement: An alternative practical predictor for early kidney dysfunction in patients with non-alcoholic fatty liver disease
14. Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study
15. FRI039 - A combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels.
16. SAT230 - Efficacy and safety of rivaroxaban in portal vein thrombosis in patients with liver decompensated cirrhosis.
17. FRI270 - Diagnostic value of magnetic resonance elastography in cirrhotic portal hypertension.
18. THU412 - A phase 2, open-label study of pan-genotype regimen of SH229 plus daclatasvir in Chinese patients with chronic hepatitis C virus infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.